Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Amortization of Deferred Charges (2017 - 2024)

Jaguar Health (JAGX) has disclosed Amortization of Deferred Charges for 9 consecutive years, with $274000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Amortization of Deferred Charges fell 78.53% to $274000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $274000.0, a 97.93% decrease, with the full-year FY2024 number at $274000.0, down 97.93% from a year prior.
  • Amortization of Deferred Charges was $274000.0 for Q1 2024 at Jaguar Health, down from $1.7 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $7.1 million in Q3 2023 to a low of $14000.0 in Q1 2020.
  • A 5-year average of $1.9 million and a median of $1.5 million in 2021 define the central range for Amortization of Deferred Charges.
  • Peak YoY movement for Amortization of Deferred Charges: crashed 92.13% in 2020, then surged 8457.14% in 2021.
  • Jaguar Health's Amortization of Deferred Charges stood at $2.0 million in 2020, then fell by 22.21% to $1.5 million in 2021, then skyrocketed by 92.91% to $3.0 million in 2022, then crashed by 42.37% to $1.7 million in 2023, then crashed by 83.98% to $274000.0 in 2024.
  • Per Business Quant, the three most recent readings for JAGX's Amortization of Deferred Charges are $274000.0 (Q1 2024), $1.7 million (Q4 2023), and $7.1 million (Q3 2023).